FOXO4dribefore and after The FOXO4-DRI peptide is a synthetic compound designed to disrupt the interaction between the FOXO4 and p53 proteins. This interaction is significant because it plays a role in cellular senescence, a state where cells stop dividing and can contribute to aging and age-related diseases. By targeting this interaction, FOXO4-DRI acts as a senolytic agent, meaning it selectively induces apoptosis (programmed cell death) in senescent cells, often referred to as "zombie cells." Research indicates that FOXO4-DRI is an investigational peptide studied for its potential role in healthy aging, aiming to remove these aging cells and restore tissue function.
FOXO4-DRI functions as a cell-penetrating peptide antagonist.FOXO4-DRI, (aka Proxofim), is a cell penetratingpeptideshown to induce apoptosis of senescent cells thereby reversing effects of aging in animal studies. Its "D-retro-inverso" design, where L-amino acids are substituted with D-amino acids, enhances its stability and cell permeability.Researchers designed a cell-penetrating peptide called FOXO4-DRI thatselectively targeted senescent cells for apoptosis and restored tissue function. This structure allows it to effectively enter cells and interfere with the binding of FOXO4 to p53. In senescent cells, FOXO4 often accumulates abnormally, preventing p53 from performing its normal functions, which include promoting apoptosis. When FOXO4-DRI treatment releases p53 from FOXO4, it can translocate to the mitochondria, triggering the release of cytochrome-c and initiating apoptosis. This mechanism is key to its senolytic properties, as it specifically targets the aberrant signaling within senescent cells.
The primary focus of FOXO4-DRI research revolves around its potential to combat age-related decline and diseases associated with cellular senescence2017年6月1日—FOXO4-DRI reversed doxorubicin-induced chemotoxicity, including increasing body weight and reducing levels of the liver damage indicator aspartate .... Studies have shown promising results in various contexts:
* Alleviating Age-Related Decline: Research has demonstrated that FOXO4-DRI improves spermatogenesis in aged mice, leading to increased sperm quality and improved reproductive function. It has also been observed to alleviate age-related testosterone secretion insufficiency by improving the testicular microenvironment.FOXO4-DRI alleviates age-related testosterone secretion ...
* Reversing Chemotoxicity: In animal models, FOXO4-DRI reversed doxorubicin-induced chemotoxicity, mitigating side effects such as weight loss and liver damage indicators. This suggests a potential role in protecting tissues from damage caused by certain medical treatments.
* Targeting Cellular Senescence: Beyond reproductive health, FOXO4-DRI treatment could remove senescent cells in various tissues, potentially enhancing tissue regeneration and function.FOX04-DRI (10mg Vial) Dosage Protocol This includes research into its effects on chondrocytes and its ability to induce apoptosis in senescent fibroblasts, such as those found in keloids.
* Broader Anti-Aging Effects: By targeting aging cells, FOX04-DRI targets aging cells to reduce inflammation, restore tissue health, and enhance stamina. Its ability to selectively target senescent cells for apoptosis and restore tissue function makes it a subject of interest for broader anti-aging strategies.
FOXO4-DRI is characterized by its synthetic nature and its specific design as a peptide antagonist.2025年6月9日—DiscoverFOXO4-DRI – a research peptide targeting senescent “zombie” cells, enhancing tissue regeneration and restoring natural hormonal ... It is often described as a high-purity peptide, with available forms including FOXO4-DRI acetate. As an investigational compound, it is primarily used for research purposes and is not approved for human diagnostic procedures. The peptide acts as a specific FOXO4 blocker, and its mechanism involves disrupting the FOXO4-p53 interaction within the nucleus of senescent cellsFOX04-DRI targets aging cellsto reduce inflammation, restore tissue health, and enhance stamina. By removing senescent cells and promoting cellular ....
While the research on FOXO4-DRI is promising, it is important to note that it remains an investigational peptide. Further studies, including potential human trials, are necessary to fully understand its efficacy, safety profile, and long-term effects. The research community is actively exploring its potential to address various age-related conditions and to promote healthier aging by clearing senescent cells. The development and study of peptides like FOXO4-DRI represent a growing area of interest in regenerative medicine and age-related disease research.
Join the newsletter to receive news, updates, new products and freebies in your inbox.